125 related articles for article (PubMed ID: 34782217)
1. Navigating through perplex morphologic changes after exogenous hormone usage.
Chang RJ; Rivera-Colon G; Chen H; Niu S; Carrick K; Lucas E; Gwin K; Zheng W
Semin Diagn Pathol; 2022 May; 39(3):148-158. PubMed ID: 34782217
[TBL] [Abstract][Full Text] [Related]
2. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
[TBL] [Abstract][Full Text] [Related]
3. [Precursor lesions of endometrial carcinoma: diagnostic approach and molecular pathology].
Lax S
Pathologe; 2011 Nov; 32 Suppl 2():255-64. PubMed ID: 22033684
[TBL] [Abstract][Full Text] [Related]
4. Management of endometrial precancers.
Trimble CL; Method M; Leitao M; Lu K; Ioffe O; Hampton M; Higgins R; Zaino R; Mutter GL;
Obstet Gynecol; 2012 Nov; 120(5):1160-75. PubMed ID: 23090535
[TBL] [Abstract][Full Text] [Related]
5. Expression and significance of beta-catenin, Glut-1 and PTEN in proliferative endometrium, endometrial intraepithelial neoplasia and endometrioid adenocarcinoma.
Xiong Y; Xiong YY; Zhou YF
Eur J Gynaecol Oncol; 2010; 31(2):160-4. PubMed ID: 20527231
[TBL] [Abstract][Full Text] [Related]
6. [Expression of beta-catenin, Glut-1, PTEN proteins in uterine endometrioid adenocarcinoma and its precursor lesions].
Xiong Y; Xiong YY; Zhou YF
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):594-9. PubMed ID: 20079187
[TBL] [Abstract][Full Text] [Related]
7. Endometrial intraepithelial neoplasia.
Owings RA; Quick CM
Arch Pathol Lab Med; 2014 Apr; 138(4):484-91. PubMed ID: 24678678
[TBL] [Abstract][Full Text] [Related]
8. Concurrent endometrial carcinoma following hysterectomy for atypical endometrial hyperplasia.
Hahn HS; Chun YK; Kwon YI; Kim TJ; Lee KH; Shim JU; Mok JE; Lim KT
Eur J Obstet Gynecol Reprod Biol; 2010 May; 150(1):80-3. PubMed ID: 20185225
[TBL] [Abstract][Full Text] [Related]
9. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Wheeler DT; Bristow RE; Kurman RJ
Am J Surg Pathol; 2007 Jul; 31(7):988-98. PubMed ID: 17592264
[TBL] [Abstract][Full Text] [Related]
10. Endometrial Intraepithelial Neoplasia (EIN) in endometrial biopsy specimens categorized by the 1994 World Health Organization classification for endometrial hyperplasia.
Li XC; Song WJ
Asian Pac J Cancer Prev; 2013; 14(10):5935-9. PubMed ID: 24289604
[TBL] [Abstract][Full Text] [Related]
11. The endometrium.
Silverberg SG
Arch Pathol Lab Med; 2007 Mar; 131(3):372-82. PubMed ID: 17516740
[TBL] [Abstract][Full Text] [Related]
12. Cervical stromal involvement by endometrial 'hyperplasia': a previously unreported phenomenon with recommendations to report as stage II endometrial carcinoma.
Taylor J; McCluggage WG
Pathology; 2021 Aug; 53(5):568-573. PubMed ID: 34154843
[TBL] [Abstract][Full Text] [Related]
13. PTEN immunohistochemistry in endometrial hyperplasia: which are the optimal criteria for the diagnosis of precancer?
Travaglino A; Raffone A; Saccone G; Mascolo M; Pignatiello S; Mollo A; De Placido G; Insabato L; Zullo F
APMIS; 2019 Apr; 127(4):161-169. PubMed ID: 30803040
[TBL] [Abstract][Full Text] [Related]
14. [Precursor lesions of endometrial carcinoma].
Lax SF
Pathologe; 2019 Feb; 40(1):13-20. PubMed ID: 30707274
[TBL] [Abstract][Full Text] [Related]
15. Computerized image analysis of p53 and proliferating cell nuclear antigen expression in benign, hyperplastic, and malignant endometrium.
Elhafey AS; Papadimitriou JC; El-Hakim MS; El-Said AI; Ghannam BB; Silverberg SG
Arch Pathol Lab Med; 2001 Jul; 125(7):872-9. PubMed ID: 11419970
[TBL] [Abstract][Full Text] [Related]
16. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.
Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B
Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463
[TBL] [Abstract][Full Text] [Related]
17. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
[TBL] [Abstract][Full Text] [Related]
18. Specific Biomarker Expression Patterns in the Diagnosis of Residual and Recurrent Endometrial Precancers After Progestin Treatment: A Longitudinal Study.
Chen H; Lucas E; Strickland AL; Carrick K; Gwin K; Castrillon DH; Rivera-Colon G; Niu S; Molberg KH; Zheng W
Am J Surg Pathol; 2020 Oct; 44(10):1429-1439. PubMed ID: 32931681
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience.
Park CK; Yoon G; Cho YA; Kim HS
Oncotarget; 2016 Jun; 7(26):39197-39206. PubMed ID: 27322430
[TBL] [Abstract][Full Text] [Related]
20. A New Hysteroscopic Risk Scoring System for Diagnosing Endometrial Hyperplasia and Adenocarcinoma.
Ianieri MM; Staniscia T; Pontrelli G; Di Spiezio Sardo A; Manzi FS; Recchi M; Liberati M; Ceccaroni M
J Minim Invasive Gynecol; 2016; 23(5):712-8. PubMed ID: 26940400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
